As of January 2026 Immunovant has a market cap of โน476.39 Billion. This makes Immunovant the world's 3036th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 14th, 2026 the market cap of Immunovant was reported to be: